Ziwei Han
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ziwei Han has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Adeyemi S. Adeleye
Columbia University
2 shared publications Jenny E. Zenobio
Department of Civil and Environmental Engineering, University of California, Irvine, CA 92617, USA
2 shared publicationsOmobayo A. Salawu
Department of Civil and Environmental Engineering, University of California, Irvine, CA 92617, USA
2 shared publicationsBolaji F. Oyeyemi
Molecular Biology Group, Department of Science Technology, The Federal Polytechnic, Ado-Ekiti, Ekiti, Nigeria
1 shared publicationJia Deng
Department of Orthopaedics, The Third Xiangya Hospital Central South University Changsha Hunan China
1 shared publication- Jian Shi
Department of Hematology and Critical Care Medicine, The Third Xiangya Hospital, Central South University, Changsha, China
1 shared publication
Latest Publications
- Open Access
- 25 May 2023
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 457, 131718
Perfluorooctanoic acid dominates the molecular-level effects of a mixture of equal masses of perfluorooctanoic acid and perfluorooctane sulfonic acid in earthworm
- 25 May 2023
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 457, 131718
Open AccessPerfluorooctanoic acid dominates the molecular-level effects of a mixture of equal masses of perfluorooctanoic acid and perfluorooctane sulfonic acid in earthworm
- 15 February 2021
- Published by Royal Society of Chemistry (RSC) in Environmental Science: Nano
- Vol. 8 (3) , 619-633
Emerging investigator series: immobilization of arsenic in soil by nanoscale zerovalent iron: role of sulfidation and application of machine learning
Despite its widespread success, nanoscale zero-valent iron (nZVI) is ineffective for the remediation of some contaminants, rapidly oxidizes in the natural environment, undergoes side reactions with water, and may be very toxic to organisms. Sulfidated nZVI (SnZVI) overcomes some of the shortcomings of nZVI in aquatic environments but studies in terrestrial systems are rare. Most existing studies either investigated the application of nanoparticles for remediation or their environmental impact, making it challenging to holistically evaluate the sustainability of nanoremediation. In this study, we simultaneously studied the immobilization of 50 ppm arsenic by nZVI and SnZVI in soil for 168 d, as well as their impact on the survival of earthworms (Eisenia fetida) during remediation. Leachable arsenic decreased by 93% and 68% after 7 d when the soil was treated with 0.3% nZVI and SnZVI, respectively. Higher arsenic immobilization was observed at higher nanoparticle dosages and longer treatment times. SnZVI performed better than nZVI when immobilized arsenic was normalized by the surface areas of both nanoparticles. An artificial neural network was successfully used to predict arsenic immobilization over time. The survival of earthworms decreased from 60% in untreated arsenic-contaminated soil to 10% when the soil was treated with 0.3% nZVI, but increased to 73% when the soil was treated with 0.3% SnZVI, showing that sulfidation decreased the toxicity of nZVI. Both nanoparticles decreased the bioaccumulation of arsenic in E. fetida, an important food source in terrestrial systems. This study demonstrates the potential of SnZVI for more sustainable remediation of arsenic in soil.
- 15 February 2021
- Published by Royal Society of Chemistry (RSC) in Environmental Science: Nano
- Vol. 8 (3) , 619-633
Emerging investigator series: immobilization of arsenic in soil by nanoscale zerovalent iron: role of sulfidation and application of machine learning
Despite its widespread success, nanoscale zero-valent iron (nZVI) is ineffective for the remediation of some contaminants, rapidly oxidizes in the natural environment, undergoes side reactions with water, and may be very toxic to organisms. Sulfidated nZVI (SnZVI) overcomes some of the shortcomings of nZVI in aquatic environments but studies in terrestrial systems are rare. Most existing studies either investigated the application of nanoparticles for remediation or their environmental impact, making it challenging to holistically evaluate the sustainability of nanoremediation. In this study, we simultaneously studied the immobilization of 50 ppm arsenic by nZVI and SnZVI in soil for 168 d, as well as their impact on the survival of earthworms (Eisenia fetida) during remediation. Leachable arsenic decreased by 93% and 68% after 7 d when the soil was treated with 0.3% nZVI and SnZVI, respectively. Higher arsenic immobilization was observed at higher nanoparticle dosages and longer treatment times. SnZVI performed better than nZVI when immobilized arsenic was normalized by the surface areas of both nanoparticles. An artificial neural network was successfully used to predict arsenic immobilization over time. The survival of earthworms decreased from 60% in untreated arsenic-contaminated soil to 10% when the soil was treated with 0.3% nZVI, but increased to 73% when the soil was treated with 0.3% SnZVI, showing that sulfidation decreased the toxicity of nZVI. Both nanoparticles decreased the bioaccumulation of arsenic in E. fetida, an important food source in terrestrial systems. This study demonstrates the potential of SnZVI for more sustainable remediation of arsenic in soil.
- 3 November 2019
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 121 (2) , 1664-1674
miR‐181b/Oncostatin m axis inhibits prostate cancer bone metastasis via modulating osteoclast differentiation
The activation of osteoblasts is significantly correlated to prostate tumor bone metastasis and bone loss. Oncostatin M (OSM) could promote breast cancer metastasis to bone. However, its role and mechanism in prostate cancer bone metastasis remain unclear. MicroRNAs (miRNAs) could play important roles in cancers via post‐transcriptionally regulating target genes via binding to specific sequences in the 3′ UTR of downstream target genes. In the present study, we performed microarray profiling analyses to identify differentially‐expressed miRNAs in preosteoclast before and after osteoclast differentiation that could target OSM. miR‐181b‐5p was downregulated during Raw264.7 cells differentiation into osteoclast. By direct targeting OSM 3′ UTR, miR‐181b‐5p inhibited OSM messenger RNA expression and protein levels, subsequently decreasing IL‐6 and AREG and increasing OPG, while OSM overexpression exerted an opposing effect. More importantly, co‐culture with miR‐181b‐5p‐overexpressing differentiated Raw264.7 cells suppressed proliferation, migration, and invasion of mouse prostate cancer RM‐1 cells, while co‐culture with OSM‐overexpressing Raw264.7 cells led to opposing cellular effects. More importantly, the effects of miR‐181b‐5p on osteoclastogenic factors and RM‐1 cells could be significantly reversed by OSM overexpression. In summary, miR‐181b‐5p/OSM axis could be a viable therapeutic target for patients with surgically removed primary tumors to reduce bone metastasis and prevent bone loss.
- 3 November 2019
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 121 (2) , 1664-1674
miR‐181b/Oncostatin m axis inhibits prostate cancer bone metastasis via modulating osteoclast differentiation
The activation of osteoblasts is significantly correlated to prostate tumor bone metastasis and bone loss. Oncostatin M (OSM) could promote breast cancer metastasis to bone. However, its role and mechanism in prostate cancer bone metastasis remain unclear. MicroRNAs (miRNAs) could play important roles in cancers via post‐transcriptionally regulating target genes via binding to specific sequences in the 3′ UTR of downstream target genes. In the present study, we performed microarray profiling analyses to identify differentially‐expressed miRNAs in preosteoclast before and after osteoclast differentiation that could target OSM. miR‐181b‐5p was downregulated during Raw264.7 cells differentiation into osteoclast. By direct targeting OSM 3′ UTR, miR‐181b‐5p inhibited OSM messenger RNA expression and protein levels, subsequently decreasing IL‐6 and AREG and increasing OPG, while OSM overexpression exerted an opposing effect. More importantly, co‐culture with miR‐181b‐5p‐overexpressing differentiated Raw264.7 cells suppressed proliferation, migration, and invasion of mouse prostate cancer RM‐1 cells, while co‐culture with OSM‐overexpressing Raw264.7 cells led to opposing cellular effects. More importantly, the effects of miR‐181b‐5p on osteoclastogenic factors and RM‐1 cells could be significantly reversed by OSM overexpression. In summary, miR‐181b‐5p/OSM axis could be a viable therapeutic target for patients with surgically removed primary tumors to reduce bone metastasis and prevent bone loss.